MedActive Oral Pharmaceuticals

MedActive Oral Pharmaceuticals is a specialty healthcare company dedicated to developing and commercializing advanced oral care solutions for patients suffering from chronic dry mouth (xerostomia) and oral mucositis. The company's product portfolio is specifically designed to address the side effects of oncology treatments, such as chemotherapy and radiation, as well as complications from autoimmune diseases like Sjögren's Syndrome. Their flagship products include Ulcerease and various MedActive Oral Relief sprays and lozenges that utilize proprietary formulations to provide long-lasting symptomatic relief. By focusing on biocompatible and sugar-free ingredients, MedActive aims to improve the quality of life and nutritional intake for patients with compromised oral health.